combine@alvar.ug

The impact of gravidity, symptomatology and timing of infection on placental malaria

The impact of gravidity, symptomatology and timing of infection on placental malaria

Show simple record

dc.contributor.author Erin E Tran
dc.contributor.author Morgan Cheeks
dc.contributor.author Abel Kakuru
dc.contributor.author Mary K Muhindo
dc.contributor.author Paul Natureeba
dc.contributor.author Miriam Nakalembe
dc.contributor.author John Ategeka
dc.contributor.author Patience Nayebare
dc.contributor.author Moses Kamya
dc.contributor.author Diane Havlir
dc.contributor.author Margaret E Feeney
dc.contributor.author Grant Dorsey
dc.contributor.author Stephanie L Gaw
dc.date.accessioned 2021-01-11T13:51:43Z
dc.date.available 2021-01-11T13:51:43Z
dc.date.issued 2020
dc.identifier.uri https://combine.alvar.ug/handle/1/49491
dc.description.abstract Abstract; Background Placental malaria is associated with increased risk of adverse perinatal outcomes. While primigravidity has been reported as a risk factor for placental malaria, little is known regarding the relationship between gravidity, symptomatology and timing of Plasmodium falciparum infection and the development of placental malaria. Methods The aim of this study was to investigate the relationship between the development of placental malaria and gravidity, timing of infection, and presence of symptoms. This is a secondary analysis of data from a double-blind randomized control trial of intermittent preventive therapy during pregnancy in Uganda. Women were enrolled from 12 to 20 weeks gestation and followed through delivery. Exposure to malaria parasites was defined as symptomatic (fever with positive blood smear) or asymptomatic (based on molecular detection of parasitemia done routinely every 4 weeks). The primary outcome was placental malaria diagnosed by histopathology, placental blood smear, and/or placental blood loop-mediated isothermal amplification. Multivariate analyses were performed using logistic regression models. Subgroup analysis was performed based on the presence of symptomatic malaria, gravidity, and timing of infection. Results Of the 228 patients with documented maternal infection with malaria parasites during pregnancy, 101 (44.3%) had placental malaria. Primigravidity was strongly associated with placental malaria (aOR 8.90, 95% CI 4.34-18.2, p<0.001), and each episode of malaria was associated with over a 2-fold increase in placental malaria (aOR 2.35, 95% CI 1.69-3.26, p<0.001). Among multigravid women, the odds of placental malaria increased by 14% with each advancing week of gestation at first documented infection (aOR 1.14, 95% CI 1.02-1.27, p=0.02). When stratified by the presence of symptoms, primigravidity was only associated with placental malaria in asymptomatic women, who had a 12-fold increase in the odds of placental malaria (aOR 12.19, 95% CI 5.23-28.43, p<0.001). Conclusions Total number of Plasmodium falciparum infections in pregnancy is a significant predictor of placental malaria. The importance of timing of infection on the development of placental malaria varies based on gravidity. In primigravidas, earlier asymptomatic infections were more frequently identified in those with placental malaria, whereas in multigravidas, parasitemias detected later in gestation were associated with placental malaria. Earlier initiation of an effective intermittent preventive therapy may help to prevent placental malaria and improve birth outcomes, particularly in primigravid women.
dc.publisher Research Square
dc.title The impact of gravidity, symptomatology and timing of infection on placental malaria
dc.type Preprint
dc.identifier.doi 10.21203/rs.3.rs-23085/v2
dc.identifier.lens 035-706-125-349-412


This record appears in the collections of the following institution(s)

Show simple record

Search Entire Database


Browse

My Account